Physician profile
Donna Johnston
NPI 1447253463
$4,600.75
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,703 · 2020: $620 · 2021: $1,624 · 2022: $326 · 2023: $328.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $328.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $328.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $1,949.59 | 2019-2023 | Xeomin |
| Biohaven Pharmaceuticals, INC. | $1,371.10 | 2020-2021 | |
| Abbvie INC. | $401.92 | 2019-2023 | Qulipta |
| Takeda Pharmaceuticals U.S.A., INC. | $188.46 | 2020-2023 | Gattex, Trintellix |
| Titan Pharmaceuticals, INC. | $125.00 | 2019 | |
| Comsort, INC | $100.00 | 2019 | |
| Allergan, INC. | $65.08 | 2019-2020 | |
| Amarin Pharma, INC. | $64.51 | 2019-2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $56.80 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $56.34 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $43.22 | 2021-2022 | |
| Pfizer INC. | $31.48 | 2019-2020 | |
| Indivior INC. | $23.72 | 2019 | |
| Lilly USA, LLC | $21.81 | 2020 | |
| Alkermes, INC. | $20.04 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $17.58 | 2019 | |
| Currax Pharmaceuticals LLC | $16.30 | 2022 | |
| Orexo US, INC. | $16.23 | 2023 | Zubsolv |
| Exact Sciences Corporation | $16.01 | 2023 | Cologuard Collection Kit |
| Almatica Pharma LLC | $15.56 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donna Johnston listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.